This miRNA is known to be positively regulated by beta-catenin directly in human gastric cancer [10] and to inhibit the Wnt/beta-catenin pathway in turn by targeting LRP6 in 3 T3-L1 cells [11]. This evidence concerns the gene LRP6 and gastric cancer.